MIAMI, Sept. 19, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company that is developing human anti-thymocyte ...

K1x Expands Aggregator Plus® with W-2 Data Extraction, Delivering a Unified, Patented Platform for K-1, 1099, and W-2 Automation K1x Inc., the fintech company behind the industry-leading Aggregator ...

-As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect with many T1D thought leaders that will participate in ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aera Therapeutics, a biotechnology company harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic ...

Earlier this month, President Donald Trump focused his ire on Portland and suggested National Guard troops may storm the city. Likening Portland to “living in hell,” Trump said protesters had ruined ...

Forbes contributors publish independent expert analyses and insights. Pam Danziger reports on retail, focused on the luxury consumer market. Following recent high-profile cyberattacks against LVMH, ...

LAS VEGAS - Hyperscale Data, Inc. (NYSE American:GPUS) announced Monday plans to distribute a special one-time dividend of 20 million shares of its Class B Common Stock to eligible shareholders. The ...

Data center capacity has become a barometer for both the health of the tech market and the risk of an A.I. bubble. By Ian Frisch Trillions of dollars are flowing into the data centers needed to power ...